Indefinite Delivery Contract SPE2DX15D5002

This federal contract IDV award, with ID SPE2DX15D5002, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

The DLA Troop Support Medical has issued numerous delivery orders under this IDC to Amerisourcebergen, with ceiling values ranging from a few dollars to over $49,000. These delivery orders are for the provision of various pharmaceutical and medical commodities, such as prescription medications, over-the-counter drugs, and critical care materials, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contracts have firm fixed-price pricing structures and ultimate completion dates ranging from 2023 to 2025, demonstrating the ongoing, long-term nature of the procurement relationship between Amerisourcebergen and the DLA Troop Support Medical.